{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:00:14Z","timestamp":1790139614469,"version":"4.0.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the efficacy of the treatment of choroidal metastasis with combined photodynamic therapy (PDT) and intravitreal bevacizumab (IVB) and compare it with PDT alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective analysis of 41 choroidal metastatic tumors: 19 tumors (13 patients) treated with PDT + IVB versus 22 tumors (8 patients) treated with PDT alone between 2011 and 2023. Outcomes measured included best-corrected visual acuity, tumor dimensions, central macular thickness, and subretinal fluid at baseline, 6 weeks, and final follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      With median follow-up of 7 (range: 3\u201384) months, the PDT + IVB group showed significantly better outcomes than the PDT alone group: improved best-corrected visual acuity at 6 weeks and final visit (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02), higher complete subretinal fluid resolution at 6 weeks (68% vs. 27%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), and significant decrease in tumor thickness at both timepoints (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004). The PDT alone group showed no significant change in tumor thickness. Tumor control rates (defined by fluid resolution and decreased thickness) were superior in the PDT + IVB group at 6 weeks (73.3% vs. 26.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009) and final visit (92% vs. 47%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This first series using combined PDT + IVB for choroidal metastasis demonstrates superior early and long-term functional and anatomical outcomes compared with PDT alone, suggesting it as a more effective management approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004566","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T16:00:09Z","timestamp":1751040009000},"page":"2131-2141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["TREATMENT OF CHOROIDAL METASTASIS WITH COMBINED PHOTODYNAMIC THERAPY AND BEVACIZUMAB AND COMPARISON WITH PHOTODYNAMIC THERAPY ALONE"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-1992","authenticated-orcid":false,"given":"Aslan","family":"Aykut","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"},{"name":"Department of Ophthalmology, Marmara University Medical School, Istanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almila","family":"Sarigul Sezenoz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"},{"name":"Department of Ophthalmology, Ba\u015fkent University, Faculty of Medicine, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buse Guneri","family":"Beser","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarinee","family":"Juntipwong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehriban","family":"Alizade","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251021","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","article-title":"Survey of 520 eyes with uveal metastases","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"R2-20251021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2015.09.033","article-title":"Photodynamic therapy for choroidal metastasis","volume":"161","author":"Ghodasra","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R3-20251021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/meajo.MEAJO_6_18","article-title":"Uveal metastasis: clinical features and survival outcome of 2214 tumors in 1111 patients based on primary tumor origin","volume":"25","author":"Shields","year":"2018","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R4-20251021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.oret.2019.10.009","article-title":"Photodynamic therapy for choroidal metastasis tumor control and visual outcomes in 58 cases: the 2019 burnier international ocular pathology society lecture","volume":"4","author":"Shields","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R5-20251021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0301-4738.154380","article-title":"Choroidal metastases: origin, features, and therapy","volume":"63","author":"Shields","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"R6-20251021","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/IAE.0000000000003433","article-title":"Photodynamic therapy for the treatment of choroidal metastases: a Case Series and Meta-analysis","volume":"42","author":"Nguyen","year":"2022","journal-title":"Retina (Philadelphia, PA)"},{"key":"R7-20251021","doi-asserted-by":"crossref","first-page":"bcr2016216273","DOI":"10.1136\/bcr-2016-216273","article-title":"Effect of treatment of rectal cancer metastasis with intravitreal bevacizumab (Avastin) in patient with subretinal fluid and macular oedema: short-term follow-up","volume":"2016","author":"Boss","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R8-20251021","doi-asserted-by":"crossref","first-page":"bcr2016215719","DOI":"10.1136\/bcr-2016-215719","article-title":"Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer","volume":"2016","author":"Nadiminti","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R9-20251021","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12032-014-0901-z","article-title":"Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature","volume":"31","author":"Maturu","year":"2014","journal-title":"Med Oncol"},{"key":"R10-20251021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0301-4738.151465","article-title":"The effect of intravitreal bevacizumab and transpupillary thermotherapy on choroidal metastases and literature review","volume":"63","author":"Lin","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"R11-20251021","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canrad.2016.09.019","article-title":"Choroidal metastasis from a lung adenocarcinoma treated by intravitreal injection of anti-VEGF and external beam radiotherapy: a case report [in French]","volume":"21","author":"Menoux","year":"2017","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"R12-20251021","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/eye.2014.96","article-title":"Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series","volume":"28","author":"Fenicia","year":"2014","journal-title":"Eye (London, England)"},{"key":"R13-20251021","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4103\/JOCO.JOCO_54_20","article-title":"Intravitreal bevacizumab (Avastin) as an adjuvant therapy for choroidal carcinoid metastasis","volume":"32","author":"Karimi","year":"2020","journal-title":"J Curr Ophthalmol"},{"key":"R14-20251021","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jcjo.2014.06.008","article-title":"Treatment of ocular metastasis with anti-VEGF: a literature review and case report","volume":"49","author":"Augustine","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"R15-20251021","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.oret.2022.01.015","article-title":"Treatment of choroidal hemangioma with photodynamic therapy and bevacizumab","volume":"6","author":"Durrani","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R16-20251021","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2005.03.030","article-title":"Optical coherence tomography characteristics of choroidal metastasis","volume":"112","author":"Arevalo","year":"2005","journal-title":"Ophthalmology"},{"key":"R17-20251021","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/IAE.0000000000000083","article-title":"Enhanced depth imaging optical coherence tomography of choroidal metastasis","volume":"34","author":"Demirci","year":"2014","journal-title":"Retina (Philadelphia, PA)"},{"key":"R18-20251021","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ophtha.2011.12.024","article-title":"Photodynamic therapy for choroidal metastasis in 8 cases","volume":"119","author":"Kaliki","year":"2012","journal-title":"Ophthalmology"},{"key":"R19-20251021","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/ph3051507","article-title":"Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities","volume":"3","author":"Olivo","year":"2010","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"R20-20251021","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00018-009-0016-4","article-title":"The effect of photodynamic therapy on tumor angiogenesis","volume":"66","author":"Bhuvaneswari","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"R21-20251021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pdpdt.2018.06.008","article-title":"Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer","volume":"23","author":"Peng","year":"2018","journal-title":"Photodiagnosis Photodynamic Ther"},{"key":"R22-20251021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.eye.6702647","article-title":"Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up","volume":"21","author":"Amselem","year":"2007","journal-title":"Eye (London, England)"},{"key":"R23-20251021","first-page":"468","article-title":"Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab","volume":"7","author":"D'Antonio","year":"2012","journal-title":"J Thorac Oncol official Publ Int Assoc Study Lung Cancer"},{"key":"R24-20251021","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/j.1755-3768.2009.01684.x","article-title":"Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab","volume":"88","author":"Yao","year":"2010","journal-title":"Acta ophthalmologica"},{"key":"R25-20251021","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ophtha.2020.07.038","article-title":"Responsiveness of vision-specific and general quality of life metrics to ocular and systemic events in patients with uveitis","volume":"127","author":"Sugar","year":"2020","journal-title":"Ophthalmology"},{"key":"R26-20251021","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ophtha.2017.05.015","article-title":"Longitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapy","volume":"124","author":"Sugar","year":"2017","journal-title":"Ophthalmology"},{"key":"R27-20251021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4103\/2008-322X.170353","article-title":"Circumscribed choroidal hemangioma","volume":"10","author":"Nourinia","year":"2015","journal-title":"J Ophthalmic Vis Res"},{"key":"R28-20251021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bjophthalmol-2013-303519","article-title":"Management of patients with uveal metastases at the liverpool ocular oncology centre","volume":"98","author":"Konstantinidis","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R29-20251021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/bjophthalmol-2019-314755","article-title":"Photoreceptor morphology and correlation with subretinal fluid chronicity associated with choroidal nevus","volume":"104","author":"Yaghy","year":"2020","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:00:40Z","timestamp":1761073240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004566","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}